Artedrone, a Truffle Capital's medtech portfolio company developing an autonomous micro robotic platform to perform and democratize mechanical thrombectomy procedures to treat patients suffering from ...
According to new research from the University of Missouri School of Medicine, the number of mechanical thrombectomies performed at hospitals is not an accurate indicator of patient outcomes, which can ...